Immunofluorescent staining confirmed that CBP was highly expressed in nuclei of glioma cells expressing the GSC markers SOX2 and OLIG2 in primary human GBMs (Appendix Fig S5C and D). This evidence concerns the gene OLIG2 and central nervous system cancer.